{"id":2454,"date":"2022-05-11T00:14:29","date_gmt":"2022-05-11T00:14:29","guid":{"rendered":"https:\/\/www.saintjohnscancer.org\/blog\/?p=2454"},"modified":"2024-06-04T17:07:01","modified_gmt":"2024-06-04T17:07:01","slug":"what-participating-in-a-clinical-trial-is-like","status":"publish","type":"post","link":"https:\/\/www.saintjohnscancer.org\/blog\/clinical-trials\/what-participating-in-a-clinical-trial-is-like\/","title":{"rendered":"What is it Like to Participate in a Clinical Trial?"},"content":{"rendered":"\n

Mark Perzely was diagnosed with Small Cell Carcinoma<\/a>—a rare and aggressive cancer which developed in his bladder, occurs in only 0.5 to 0.7 percent of all bladder cancers<\/a> and has a median survival rate of 1.7 years. The cell growth rate for these cells is distinctly rapid. “Once small-cell spreads, it won’t stop, and there are no approved treatments,” Mark announced in his testimonial. According to the journal of Clinical Genitourinary Cancer<\/a>, there are no standard guidelines for the disease either, which makes Mark’s recovery even more impressive.<\/p>\n

\n

[Clinical trials are] a win-win situation if there are no other options available… or seems to be the best option.<\/span><\/p><\/blockquote>\n<\/div>\n

Who benefits from clinical trials?<\/h2>\n

Procedures and medications which undergo a clinical trial are beneficial because the need<\/em> to address a disease that has no standard treatment is imperative<\/em>. The results of the trial may lead to approved and administered treatments globally. Those patients who have a rare disease or late-stage cancer notably benefit because these treatments tend to be groundbreaking, resulting in the prolonging of one’s life, similar to Mark’s. It is also critical that patients explore the trials available to them long before they become a last resort.<\/em><\/p>\n

Listen to Mark detail his prognosis and clinical trial experience<\/h3>\n